CIViC Compass
Research use only — not FDA-cleared, not medical advice. Always consult FDA-approved labeling and a qualified clinician.
Home/Biomarker

IDH1 mutation (cholangiocarcinoma)

Gene: IDH1 · Type: mutation

Indications: Cholangiocarcinoma

SensitivityResistanceCIViC Context

FDA Sensitivity Assertions

DrugIndicationRecommendationFDA SourceLink
IvosidenibCholangiocarcinomaINDICATED
FDA Label
Label